Transporters are an under-developed therapeutic target. Discuss
β Scribed by Steve Alexander
- Book ID
- 111219930
- Publisher
- Nature Publishing Group
- Year
- 2011
- Tongue
- English
- Weight
- 115 KB
- Volume
- 164
- Category
- Article
- ISSN
- 0007-1188
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The production of diseaseβtargeted agents requires the covalent conjugation of a targeting molecule with a contrast agent or therapeutic, followed by purification of the product to homogeneity. Typical targeting molecules, such as small molecules and peptides, often have high chargeβtoβ
Rat embryos (gestation days 9.0 and 10.0) obtained from dams that were fed a Cu-adequate (8 micrograms Cu/g) or Cu-deficient (< 0.5 micrograms Cu/g diet were cultured for 48 hr in Cu-adequate (16.2 microM) or Cu-deficient (1.0 microM) rat serum. Control embryos cultured in control serum were morphol